Sep 01, 2026
599:500
For every 500 shares held, investors received 599. The price per share adjusted from $4.89 to $4.08.
The split itself did not change the total investment value.
OncoZenge AB (STO:ONCOZ) operates in the Pharmaceuticals: major industry.
OncoZenge AB company overviewOncoZenge AB's most recent stock split was on September 1, 2026. It was a 599-for-500 forward split, so shareholders received 599 shares for every 500 they held.
OncoZenge AB (STO:ONCOZ) has split its stock 2 times: a 672-for-541 split on February 16, 2021 and a 599-for-500 split on September 1, 2026.
OncoZenge AB has split its stock 2 times. This history records 2 forward splits between February 16, 2021 and September 1, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In OncoZenge AB's 599-for-500 split on September 1, 2026, every 500 shares became 599 shares.
OncoZenge AB has not announced a new split in our records. Its most recent split was on September 1, 2026, less than a year ago. Companies announce splits in advance, and any new STO:ONCOZ split will appear on this page.
Already premium?